IQVIA Holdings(us:IQV)
197.69
+0.21%
Updated on 2024-12-23
Open:196.53
Close:197.69
High:198.68
Low:195.37
Pre Close:197.27
Volume:838503.00
Amount:165.75M
Turnover:0.46%
Shares:181.50M
MarketCap:35.88B
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 33 | 180793 | 0.10% | 4 | 11 | 9 |
| 2024-03-31 | 1020 | 157595444 | 86.50% | 113 | 373 | 394 |
| 2023-12-31 | 1019 | 162524659 | 89.54% | 117 | 270 | 509 |
| 2023-09-30 | 976 | 160455288 | 87.92% | 96 | 343 | 402 |
| 2023-06-30 | 971 | 158680900 | 86.66% | 90 | 329 | 415 |
| 2023-03-31 | 941 | 196511275 | 105.93% | 81 | 338 | 389 |
| 2022-12-31 | 954 | 161605183 | 87.00% | 114 | 298 | 425 |
| 2022-09-30 | 926 | 160109941 | 86.17% | 75 | 322 | 401 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-06-30 | Vanguard Group Inc | 20283577 | 11.13% | -784684 | -3.72% |
| 2024-06-30 | Blackrock Inc. | 15234992 | 8.36% | -155409 | -1.01% |
| 2024-06-30 | Harris Associates L P | 10671294 | 5.85% | 527906 | 5.20% |
| 2024-06-30 | State Street Corp | 8028119 | 4.40% | 66076 | 0.83% |
| 2024-06-30 | Geode Capital Management, Llc | 4221991 | 2.32% | 66048 | 1.59% |
| 2024-06-30 | Morgan Stanley | 4084172 | 2.24% | 97563 | 2.45% |
| 2024-06-30 | Alliancebernstein L.P. | 4023229 | 2.21% | -200334 | -4.74% |
| 2024-06-30 | Canada Pension Plan Investment Board | 3403488 | 1.87% | 211653 | 6.63% |
| 2024-06-30 | Lazard Asset Management Llc | 3288515 | 1.80% | 24571 | 0.75% |
| 2024-06-30 | Farallon Capital Management Llc | 2923032 | 1.60% | 86870 | 3.06% |
About
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions, and real-world solutions and services to the firm's life science clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.
Address:2400 Ellis Road
Website:http://www.iqvia.com
Market Movers